Patent delisted for Abbvie drug KALETRA

Annual Drug Patent Expirations for KALETRA Kaletra is a drug marketed by Abbvie and is included in three NDAs. It is available from three suppliers. KALETRA drug price trends. Drug…

The post Patent delisted for Abbvie drug KALETRA appeared first on DrugPatentWatch - Make Better Decisions.

Comments are closed.